Css LLC Axsome Therapeutics, Inc. Transaction History

Css LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $31,432 - $62,739	-787 Reduced 6.9%	10,613 $818,000
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $411,084 - $796,289	11,400 New	11,400 $509,000
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $371,807 - $525,132	12,111 Added 188.12%	18,549 $701,000
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $6,729 - $23,071	338 Added 5.54%	6,438 $212,000
Q2 2021 Aug 16, 2021	SELL	$50.63 - $73.5 $50,630 - $73,500	-1,000 Reduced 14.08%	6,100 $412,000
Q1 2021 May 17, 2021	BUY	$55.91 - $81.44 $262,777 - $382,768	4,700 Added 195.83%	7,100 $402,000
Q4 2020 Feb 16, 2021	BUY	$66.31 - $86.52 $33,155 - $43,260	500 Added 26.32%	2,400 $196,000
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $108,728 - $136,571	-1,591 Reduced 45.57%	1,900 $135,000
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $3.29 Million - $6.52 Million	-66,057 Reduced 94.98%	3,491 $287,000
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $1.16 Million - $7.39 Million	69,548 New	69,548 $7.19 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.